Journal of Clinical Medicine | World Hepatitis Day in 2023—“We’re not waiting”
World Hepatitis Day (WHD), held on 28 July every year, aims to raise global awareness of hepatitis—a group of infectious diseases known as hepatitis A, B, C, D, and E—and encourage prevention, diagnosis, and treatment, where we bring the world together under a single theme to raise awareness of the global burden of viral hepatitis and to influence real change. In 2023, the theme is “We’re not waiting”, and we call on people around the world to take action because hepatitis can’t wait.
To further explore the related research on the World Hepatitis Day 2023, Journal of Clinical Medicine (JCM, ISSN: 2077-0383) has gathered open access academic research on the topic of hepatitis. We hope to share new scientific knowledge in the field of hepatitis with the world on this special day.
Article Collections:
1. "CD8+ T Cell Responses during HCV Infection and HCC"
by Maike Hofmann, Catrin Tauber, Nina Hensel and Robert Thimme
J. Clin. Med. 2021, 10(5), 991; https://doi.org/10.3390/jcm10050991
2. "Hepatocellular Carcinoma Recurrence after Hepatitis C Virus Therapy with Direct-Acting Antivirals. A Systematic Review and Meta-Analysis"
by Leonardo Frazzoni, Usama Sikandar, Flavio Metelli, Sinan Sadalla, Giuseppe Mazzella, Franco Bazzoli, Lorenzo Fuccio and Francesco Azzaroli
J. Clin. Med. 2021, 10(8), 1694; https://doi.org/10.3390/jcm10081694
3. "Laboratory Profile of COVID-19 Patients with Hepatitis C-Related Liver Cirrhosis"
by Bianca Cerbu, Mirela Loredana Grigoras, Felix Bratosin, Iulia Bogdan, Cosmin Citu, Adrian Vasile Bota, Madalina Timircan, Melania Lavinia Bratu, Mihaela Codrina Levai and Iosif Marincu
J. Clin. Med. 2022, 11(3), 652; https://doi.org/10.3390/jcm11030652
4. "Tracking Down the Epigenetic Footprint of HCV-Induced Hepatocarcinogenesis"
by Tom Domovitz and Meital Gal-Tanamy
J. Clin. Med. 2021, 10(3), 551; https://doi.org/10.3390/jcm10030551
5. "Immunological Mechanisms for Hepatocellular Carcinoma Risk after Direct-Acting Antiviral Treatment of Hepatitis C Virus Infection"
by Pil Soo Sung and Eui-Cheol Shin
J. Clin. Med. 2021, 10(2), 221; https://doi.org/10.3390/jcm10020221
6. "Rapid Decline of Serum Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) in Non-Cirrhotic Patients with Chronic Hepatitis C Infection Receiving Direct-Acting Antiviral Therapy"
by Jonathan Grimm, Georg Peschel, Martina Müller, Doris Schacherer, Reiner Wiest, Kilian Weigand and Christa Buechler
J. Clin. Med. 2021, 10(8), 1621; https://doi.org/10.3390/jcm10081621
7. "Day-4 Lille Score Is a Good Prognostic Factor and Early Predictor in Assessing Therapy Response in Patients with Liver Cirrhosis and Severe Alcoholic Hepatitis"
by Camelia Gianina Foncea, Ioan Sporea, Raluca Lupușoru, Tudor Voicu Moga, Felix Bende, Roxana Șirli and Alina Popescu
J. Clin. Med. 2021, 10(11), 2338; https://doi.org/10.3390/jcm10112338
8. "Hepatitis C: A Pharmacological Therapeutic Update"
by Sonia Santander Ballestín, David Gómez Martín, Sara Lorente Pérez and María José Luesma Bartolomé
J. Clin. Med. 2021, 10(8), 1568; https://doi.org/10.3390/jcm10081568
9. "Zinc Administration and Improved Serum Markers of Hepatic Fibrosis in Patients with Autoimmune Hepatitis"
by Kei Moriya, Norihisa Nishimura, Tadashi Namisaki, Hiroaki Takaya, Yasuhiko Sawada, Hideto Kawaratani, Kosuke Kaji, Naotaka Shimozato, Shinya Sato, Masanori Furukawa et al.
J. Clin. Med. 2021, 10(11), 2465; https://doi.org/10.3390/jcm10112465
10. "Association between Visceral Adipose Tissue and Non-Alcoholic Steatohepatitis Histology in Patients with Known or Suspected Non-Alcoholic Fatty Liver Disease"
by Ilkay S. Idilman, Hsien Min Low, Tolga Gidener, Kenneth Philbrick, Taofic Mounajjed, Jiahui Li, Alina M. Allen, Meng Yin and Sudhakar K. Venkatesh
J. Clin. Med. 2021, 10(12), 2565; https://doi.org/10.3390/jcm10122565
11. "Transplantation of Organs from Hepatitis C Virus-Positive Donors under Direct-Acting Antiviral Regimens"
by Muhammad Nauman Zahid
J. Clin. Med. 2022, 11(3), 770; https://doi.org/10.3390/jcm11030770
12. "Extrahepatic Manifestations of Chronic HBV Infection and the Role of Antiviral Therapy"
by Cesare Mazzaro, Luigi Elio Adinolfi, Gabriele Pozzato, Riccardo Nevola, Ada Zanier, Diego Serraino, Pietro Andreone, Roberta Fenoglio, Savino Sciascia, Valter Gattei et al.
J. Clin. Med. 2022, 11(21), 6247; https://doi.org/10.3390/jcm11216247
13. "Use of a Deep Learning Approach for the Sensitive Prediction of Hepatitis B Surface Antigen Levels in Inactive Carrier Patients"
by Hiroteru Kamimura, Hirofumi Nonaka, Masaya Mori, Taichi Kobayashi, Toru Setsu, Kenya Kamimura, Atsunori Tsuchiya and Shuji Terai
J. Clin. Med. 2022, 11(2), 387; https://doi.org/10.3390/jcm11020387
14. "Micro-Elimination of Hepatitis C among Patients with Kidney Disease by Using Electronic Reminder System—A Hospital-Based Experience"
by Pei-Yuan Su, Wei-Wen Su, Yu-Chun Hsu, Shu-Yi Wang, Ping-Fang Chiu and Hsu-Heng Yen
J. Clin. Med. 2022, 11(2), 423; https://doi.org/10.3390/jcm11020423
15. "Hepatitis B Core-Related Antigen Is Useful for Predicting Phase and Prognosis of Hepatitis B e Antigen-Positive Patients"
by Han Ah Lee, Hyun Woong Lee, Younhee Park, Hyon-Suk Kim and Yeon Seok Seo
J. Clin. Med. 2022, 11(6), 1729; https://doi.org/10.3390/jcm11061729
Access more articles:
https://www.mdpi.com/search?journal=jcm.
Call for Paper:
"Clinical Advances in Viral Hepatitis"
Guest Editor: Prof. Dr. Calvin Q. Pan
Submission Deadline: 30 September 2023
"New Advances in Management of Hepatitis B Virus (HBV) Infection"
Guest Editors: Dr. Maryam Moini and Dr. Scott K. Fung
Submission Deadline: 25 November 2023
Access more Special Issues:
https://www.mdpi.com/journal/jcm/special_issues?section_id=491&search=&sort=deadline&view=open&page_count=100.
Special Issue Book:
“Chronic HCV Infection: Clinical Advances and Eradication Perspectives”
Access more Special Issue books:
https://www.mdpi.com/books/search?type=Reprint%20Book&journal_facet=Journal%20of%20Clinical%20Medicine.